A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
Chauhan D; Velankar M; Brahmandam M; Hideshima T; Podar K; Richardson P; Schlossman R; Ghobrial I; Raje N; Munshi N; Anderson KC; Oncogene, 2007, vol. 26, issue 16, p 2374, ISSN 09509232. ISBN 09509232.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef